Nef from a primary isolate of human immunodeficiency virus type 1 lacking the EE155 region shows decreased ability to down-regulate CD4

Journal of General Virology

Volumn 85, Issue 6, 2004, Pages 1451-1461

  Na, Young Soon ^a   Yoon, Keejung ^a   Nam, Jeong Gu ^b   Choi, Byeongsun ^b   Lee, Joo Shil ^b   Kato, Ikunoshin ^c   Kim, Sunyoung ^a  

^a Seoul National University   (South Korea)

^b Korea National Institute of Health   (South Korea)

^c TAKARA BIO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLUTAMIC ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; GENE TARGETING; GENE TRANSFER; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN ISOLATION; SEQUENCE ANALYSIS; T LYMPHOCYTE; VIRUS STRAIN; AMINO ACID SEQUENCE; CHEMISTRY; LEUKEMIA CELL LINE; MOLECULAR GENETICS; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ANTIGENS, CD4; DOWN-REGULATION; GENE PRODUCTS, NEF; HIV-1; HUMANS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 2942666032     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.79803-0     Document Type: Article

References (32)

1. Arora, V. K., Fredericksen, B. L. & Garcia, J. V. (2002). Nef. agent of cell subversion. Microbes Infect 4, 189-199.
2. Asamitsu, K., Morishima, T., Tsuchie, H., Kurimura, T. & Okamoto, T. (1999). Conservation of the central proline-rich (PxxP) motifs of human immunodeficiency virus type 1 Nef protein during the disease progression in two hemophiliac patients. FEBS Lett 459, 399-404.
3. Benichou, S., Bomsel, M., Bodeus, M., Durand, H., Doute, M., Letourneur, F., Camonis, J. & Benarous, R. (1994). Physical interaction of the HIV-1 Nef protein with beta-COP, a component of n on-clathrin-coated vesicles essential for membrane traffic. J Biol Chem 269, 30073-30076.
4. Benson, R. E., Sanfridson, A., Ottinger, J. S., Doyle, C. & Cullen, B. R. (1993). Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med 177, 1561-1566.
5. Bresnahan, P. A., Yonemoto, W., Ferrell, S., Williams-Herman, D., Geleziunas, R. & Greene, W. C. (1998). A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol 8, 1235-1238.
6. Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. & Baltimore, D. (1998). HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401.
7. Craig, H. M., Pandori, M. W. & Guatelli, J. C. (1998). Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc Natl Acad Sci U S A 95, 11229-11234.
8. Garcia, J. V. & Miller, A. D. (1991). Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511.
9. Geyer, M. & Peterlin, B. M. (2001). Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef. FEBS Lett 496, 91-95.
10. Geyer, M., Munte, C. E., Schorr, J., Kellner, R. & Kalbitzer, H. R. (1999). Structure of the anchor-domain of myristoylated and non-myristoylated HIV-1 Nef protein. J Mol Biol 289, 123-138.
11. Geyer, M., Fackler, O. T. & Peterlin, B. M. (2001). Structure-function relationships in HIV-1 Nef. EMBO Rep 2, 580-585.
12. Greenberg, M., DeTulleo, L., Rapoport, I., Skowronski, J. & Kirchhausen, T. (1998a). A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. Curr Biol 8, 1239-1242.
13. Greenberg, M. E., Iafrate, A. J. & Skowronski, J. (1998b). The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J 17, 2777-2789.
14. Grzesiek, S., Stahl, S. J., Wingfield, P. T. & Bax, A. (1996). The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry 35, 10256-10261.
15. Guy, B., Kieny, M. P., Riviere, Y., Le Peuch, C., Dott, K., Girard, M., Montagnier, L. & Lecocq, J. P. (1987). HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330, 266-269.
16. Janvier, K., Craig, H., Le Gall, S., Benarous, R., Guatelli, J., Schwartz, O. & Benichou, S. (2001). Nef-induced CD4 down-regulation: a diacidic sequence in human immunodeficiency virus type 1 Nef does not function as a protein sorting motif through direct binding to beta-COP. J Virol 75, 3971-3976.
17. Kestler, H. W., III, Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D. & Desrosiers, R. C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
18. Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L. & Desrosiers, R. C. (1995). Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332, 228-232.
19. Lama, J., Mangasarian, A. & Trono, D. (1999). Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Environ incorporation in a Nef- and Vpu-inhibitable manner. Curr Biol 9, 622-631.
20. Lee, J. T., Yu, S. S., Han, E. & Kim, S. (2004). Engineering the splice acceptor for improved gene expression and viral titer in an MLV-based retroviral vector. Gene Ther 11, 94-99.
21. Mangasarian, A., Piguet, V., Wang, J. K., Chen, Y. L. & Trono, D. (1999). Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J Virol 73, 1964-1973.
22. Mariani, R. & Skowronski, J. (1993). CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proc Natl Acad Sci U S A 90, 5549-5553.
23. Nunn, M. F. & Marsh, J. W. (1996). Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J Virol 70, 6157-6161.
24. Parnes, J. R. & Seong, R. H. (1994). CD4 and CD8 in T cell lineage commitment: alterations induced by expression of a CD8/CD4 chimeric transgene. Semin Immunol 6, 221-229.
25. Piguet, V., Gu, F., Foti, M., Demaurex, N., Gruenberg, J., Carpentier, J. L. & Trono, D. (1999). Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 97, 63-73.
26. Piguet, V., Wan, L., Borel, C., Mangasarian, A., Demaurex, N., Thomas, G. & Trono, D. (2000). HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat Cell Biol 2, 163-167.
27. Ross, T. M., Oran, A. E. & Cullen, B. R. (1999). Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr Biol 9, 613-621.
28. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. & Heard, J. M. (1996). Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2, 338-342.
29. Soneoka, Y., Cannon, P. M., Ramsdale, E. E., Griffiths, J. C., Romano, G., Kingsman, S. M. & Kingsman, A. J. (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23, 628-633.
30. Stoddart, C. A., Geleziunas, R., Ferrell, S. & 8 other authors (2003). Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis. J Virol 77, 2124-2133.
31. Wysocki, L. J. & Sato, V. L. (1978). "Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A 75, 2844-2848.
32. Yoon, K., Jeong, J. G., Yoon, H., Lee, J. S. & Kim, S. (2001). Differential effects of primary human immunodeficiency virus type 1 nef sequences on downregulation of CD4 and MHC class I. Biochem Biophys Res Commun 284, 638-642.